Medicines losing patent protection

MonthYear

September 2027

2 medicines lose their last listed patent or exclusivity in September 2027.

Sep 15Edurantrilpivirine hydrochloride · Janssen Products LP
Sep 26Emendaprepitant · Merck Sharp and Dohme LLC

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits